Revance Therapeutics, Inc.

COMMONWEALTH EQUITY SERVICES, LLC

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/10/2025

Shares

49,333

Value ($000)

150

Weight

0.0%

2020 Q3 - 2024 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/10/2025	150	0.0%	49,333	12/31/2024
2024 Q3	10/18/2024	405	0.0%	78,041	9/30/2024
2024 Q2	7/31/2024	282	0.0%	109,917	6/30/2024
2024 Q1	4/29/2024	533	0.0%	108,376	3/31/2024
2023 Q4	2/6/2024	977	0.0%	111,144	12/31/2023
2023 Q3	10/23/2023	1,137	0.0%	99,129	9/30/2023
2023 Q2	8/10/2023	2,421	0.0%	95,651	6/30/2023
2023 Q1	5/11/2023	2,859	0.0%	88,768	3/31/2023
2022 Q4	2/7/2023	1,639	0.0%	88,819	12/31/2022
2022 Q3	11/14/2022	2,047	0.0%	75,825	9/30/2022
2022 Q2	7/19/2022	453	0.0%	32,813	6/30/2022
2022 Q1	5/4/2022	591	0.0%	30,313	3/31/2022
2021 Q4	1/31/2022	403	0.0%	24,715	12/31/2021
2021 Q3	10/29/2021	589	0.0%	21,160	9/30/2021
2021 Q2	8/11/2021	448	0.0%	15,137	6/30/2021
2021 Q1	5/4/2021	427	0.0%	15,285	3/31/2021
2020 Q4	2/11/2021	373	0.0%	13,182	12/31/2020
2020 Q3	11/5/2020	316	0.0%	12,594	9/30/2020